Chinese Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

6 companies

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥24.9b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥94.09

-4.8%

47.0%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥31.3b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥67.89

1.6%

61.0%

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.8b

Shanghai Rightongene Biotechnology Co., Ltd.

688217

CN¥31.79

5.1%

62.3%

Chongqing Zhifei Biological Products

Market Cap: CN¥45.3b

Chongqing Zhifei Biological Products Co., Ltd.

300122

CN¥18.92

-4.4%

-23.9%

Shenzhen Kangtai Biological Products

Market Cap: CN¥17.5b

Shenzhen Kangtai Biological Products Co., Ltd.

300601

CN¥15.63

-2.0%

3.6%

Nanjing Vazyme Biotech

Market Cap: CN¥8.7b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥21.85

2.1%

3.4%